Luis Garcia-Fernandez

Mr. Luis Garcia-Fernandez

Mechanical and Aerospace Engineering, University of California, Irvine, Irvine, California, USA
orcid

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 November 2024 in Sensors
Verified
Journal Article
Open access
PDF file
Guillem Cornella-BarbaGuillem Cornella-Barba
Guillem Cornella-Barba
AFAndria Farrens
Andria Farrens
CJChristopher A. Johnson
Christopher A. Johnson
Luis Garcia-FernandezLuis Garcia-Fernandez
Luis Garcia-Fernandez
VCVicky Chan
Vicky Chan
DRDavid Reinkensmeyer
David Reinkensmeyer
Many medical conditions impair proprioception but there are few easy-to-deploy technologies for assessing proprioceptive deficits. Here, we developed a method—called “OpenPoint”—to quantify upper extremity (UE) proprioception using only a webcam as the sensor. OpenPoint automates a classic neurological test: the ability of a person to use one hand to point to a finger on their other hand with vision obscured. Proprioception ability is quantified with pointing error in the frontal plane measured by a deep-learning-based, computer vision library (MediaPipe). In a first experiment with 40 unimpaired adults, pointing error significantly increased when we replaced the target hand with a fake hand, verifying that this task depends on the availability of proprioceptive information from the target hand, and that we can reliably detect this dependence with computer vision. In a second experiment, we quantified UE proprioceptive ability in 16 post-stroke participants. Individuals post stroke exhibited increased pointing error (p < 0.001) that was correlated with finger proprioceptive error measured with an independent, robotic assessment (r = 0.62, p = 0.02). These results validate a novel method to assess UE proprioception ability using affordable computer technology, which provides a potential means to democratize quantitative proprioception testing in clinical and telemedicine environments.

17 October 2025 in Sensors
Verified
Journal Article
Open access
PDF file
CJChristopher A. Johnson
Christopher A. Johnson
AFAndria Farrens
Andria Farrens
PBPiyashi Biswas
Piyashi Biswas
Luis Garcia-FernandezLuis Garcia-Fernandez
Luis Garcia-Fernandez
JSJill See
Jill See
DRDavid Reinkensmeyer
David Reinkensmeyer
In rehabilitation research, coarse clinical outcome measures may limit the sensitivity of trials by failing to detect meaningful intervention-induced changes. Sensorized robotic platforms can potentially improve the evaluation of motor function, yet their reliability compared to skilled therapists remains unclear. This study utilized a robotic device to measure two fundamental impairments that are critical to ankle function: range of motion (ROM, active and passive) and dorsiflexion maximum voluntary contraction (MVC). In 34 chronic hemiparetic post-stroke individuals, we assessed test–retest reliability over two days for the robot and experienced therapists, who used a goniometer and manual muscle testing (MMT). We also evaluated robotic test–retest reliability in 36 young and 26 older unimpaired adults. Reliability for robotic and therapist-based AROM and MVC measures was high (ICC > 0.86), consistent across all groups. Robotic AROM and PROM measurements correlated strongly with therapist assessments (r > 0.60, p < 0.001) but were 120% and 37% larger than therapist assessments (p < 0.001), respectively. For the MVC measurement, the therapist assigned 85% of participants a score of 1 on the MMT, but their MVC torque was distributed from 0 to ~20 Nm. Measurement differences between methods likely arose from the robot’s constrained setup, allowing for compensatory muscle activation. The increased granularity provided by robotic MVC measurements could enable more precise tracking of motor recovery and facilitate tailored rehabilitation strategies. These results support the clinical utility of robotic platforms for ankle assessment, offering detailed, objective measurements that can augment traditional evaluations, and provide a benchmark dataset for other researchers.

3 October 2025 in Preprints.org
Verified
Preprint
Open access
PDF file
CJChristopher A. Johnson
Christopher A. Johnson
AFAndria Farrens
Andria Farrens
PBPiyashi Biswas
Piyashi Biswas
Luis Garcia-FernandezLuis Garcia-Fernandez
Luis Garcia-Fernandez
JSJill See
Jill See
DRDavid Reinkensmeyer
David Reinkensmeyer
In rehabilitation research, coarse clinical outcome measures may limit the sensitivity of trials by failing to detect meaningful intervention-induced changes. Sensorized robotic platforms can potentially improve the evaluation of motor function, yet their reliability compared to skilled therapists remains unclear. This study utilized a robotic device to measure two fundamental impairments that are critical to ankle function: range of motion (ROM, active and passive) and dorsiflexion maximum voluntary contraction (MVC). In 34 chronic hemiparetic post-stroke individuals, we assessed test-retest reliability over two days for the robot and experienced therapists, who used a goniometer and manual muscle testing (MMT). We also evaluated robotic test-retest reliability in 36 young and 26 older unimpaired adults. Reliability for robotic and therapist-based AROM and MVC measures was high (ICC > 0.86), consistent across all groups. Robotic AROM and PROM measure-ments correlated strongly with therapist assessments (r > 0.60, p < 0.001) but were 120% and 37% larger than therapist assessments (p < 0.001), respectively. For the MVC measurement, the therapist assigned 85% of participants a score of 1 on the MMT, but their MVC torque was distributed from 0 to ~20 Nm. Measurement differences between methods likely arose from the robot's constrained setup, allowing compensatory muscle activation. The increased granularity provided by robotic MVC measurements could enable more precise tracking of motor recovery and facilitate tailored rehabilitation strategies. These results support the clinical utility of robotic platforms for ankle assessment, offering detailed, objective measurements that can augment traditional evaluations. A supplementary dataset for benchmarking future research is provided.

27 March 2026 in Bioengineering
Verified
Journal Article
Open access
PDF file
Luis Garcia-FernandezLuis Garcia-Fernandez
Luis Garcia-Fernandez
JPJuan C. Pérez-Ibarra
Juan C. Pérez-Ibarra
AFAndria Farrens
Andria Farrens
VCVicky Chan
Vicky Chan
JMJoshua J. Macopson
Joshua J. Macopson
DRDavid Reinkensmeyer
David Reinkensmeyer
Technologies for home movement rehabilitation after stroke are rapidly expanding. However, for consumers, the number and nature of available products are unclear, and the information provided by device manufacturers varies widely. To understand this landscape, we conducted a mixed-methods, descriptive study in which we used the U.S. Food and Drug Administration (FDA) database to identify interactive devices for stroke rehabilitation suitable for home use. We then surveyed 13 individuals with stroke to determine what information they most wanted about home-based rehabilitation devices and contacted manufacturers to obtain those details. Thirteen FDA codes were associated with stroke rehabilitation devices, encompassing 57 devices produced by 40 companies. Nearly half were categorized under two codes: QKC (interactive rehabilitation exercise devices) and GZI (neuromuscular stimulators). Among devices for which information was available, 71% were listed after 2015, and 23% cost under $1000. The top information priorities for individuals with stroke were required usage to achieve therapeutic benefit, expected benefit, ease of use, and motivational features. Despite repeated outreach, only 45% of companies responded to our queries; among those that did, details were vague and variable. These results confirm that a large and growing number of FDA-listed devices are now available for home-based post-stroke motor rehabilitation. We further identify a need to establish industry standards for reporting ease of use, motivational effectiveness, and dose–response characteristics to help the intended consumers select appropriate technologies. The curated dataset generated in this study is provided as a resource for future work and may support the development of accurate Artificial Intelligence-based interfaces for identifying and comparing rehabilitation devices.

22 December 2025 in Preprints.org
Verified
Preprint
Open access
PDF file
Luis Garcia-FernandezLuis Garcia-Fernandez
Luis Garcia-Fernandez
JPJuan C. Pérez-Ibarra
Juan C. Pérez-Ibarra
AFAndria Farrens
Andria Farrens
VCVicky Chan
Vicky Chan
JMJoshua Jones Macopson
Joshua Jones Macopson
DRDavid Reinkensmeyer
David Reinkensmeyer
Technologies for home movement rehabilitation after stroke are rapidly expanding. However, for consumers, the number and nature of available products are unclear, and the information provided by device manufacturers varies widely. To understand this landscape, we used the U.S. Food and Drug Administration (FDA) database to identify devices for stroke rehabilitation suitable for home use. We then surveyed 13 individuals with stroke to determine what information they most wanted about home-based reha-bilitation devices and contacted manufacturers to obtain those details. Thirteen FDA codes were associated with stroke rehabilitation devices, encompassing 58 devices produced by 41 companies. Nearly half were categorized under two codes: QKC (in-teractive rehabilitation exercise devices) and GZI (neuromuscular stimulators). Among devices for which information was available, 71% received FDA clearance after 2015, and 23% cost under $1,000. The top information priorities for individuals with stroke were required usage to achieve therapeutic benefit, expected benefit, ease of use, and motivational features. Despite repeated outreach, only 44% of companies responded to our queries; among those that did, details were vague and variable. These results con-firm that a large and growing number of FDA-approved devices are now available for home-based post-stroke motor rehabilitation. We further identify a need to establish industry standards for reporting ease of use, motivational effectiveness, and dose–response characteristics to help the intended consumers select appropriate technolo-gies. We include the dataset for future reference.

11 January 2026 in Experimental Brain Research
Verified
Journal Article
Open access
PDF file
Luis Garcia-FernandezLuis Garcia-Fernandez
Luis Garcia-Fernandez
AFAndria Farrens
Andria Farrens
CJChristopher A. Johnson
Christopher A. Johnson
VCVicky Chan
Vicky Chan
JPJoel C. Perry
Joel C. Perry
DRDavid Reinkensmeyer
David Reinkensmeyer
The thumb plays a crucial role in hand function, yet its proprioceptive abilities remain poorly understood. Here we quantified dynamic thumb localization ability, as well as how this ability adapts to a perturbation, in unimpaired participants. For this, we developed a novel task in which a robot moved the thumb in a circle and participants pressed a button when they felt their thumb aligning with a target point on a screen, receiving visual error feedback in the form of a ball jumping toward the target after they pushed the button. The task also incorporated a propriovisual rotational perturbation to elicit and measure adaptation. To characterize thumb localization ability, we varied thumb speed and rotation diameter, assessed the effect of the propriovisual rotational perturbation, and compared index finger performance. Following task familiarization, average thumb localization error was relatively consistent, with a constant error (CE) of − 5.9°, variable error (VE) of 25.2°, and absolute error (AE) of 29.2°. Errors did not change significantly with speed or circle diameter. Reversing thumb rotation temporarily increased error followed by rapid error adaptation across the next 20 trials, as would be expected if individuals adapted using a body-centered (movement-aligned) frame of reference rather than a world-centered spatial frame. Localization error was comparable for the thumb and the index finger error for the same task and was correlated with a different, robotic assessment of finger proprioception (ρ = 0.61, p = 0.001). These findings indicate that dynamic thumb localization is somewhat inaccurate, although it can leverage visual feedback within a body-centered reference frame to adapt. Further, in unimpaired adults, the dynamic localization abilities of the thumb and index finger are related.